Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Biological Response Modifiers Influence Structure Function Relationship of Hematopoietic Stem and Stromal Cells in a Mouse Model of Leukemia

  • Basu, Kaustuv (Department of Anatomy and Cell Biology, McGill University) ;
  • Mukherjee, Joydeep (Brain Tumor Research Centre, Department of Neurosurgery, Helen Diller Family Comprehensive Cancer Centre, UCSF) ;
  • Law, Sujata (Department of Biochemistry & Medical Biotechnology, Stem Cell Research & Application Unit, Calcutta School of Tropical Medicine) ;
  • Chaudhuri, Samaresh (Department of Biochemistry & Medical Biotechnology, Stem Cell Research & Application Unit, Calcutta School of Tropical Medicine)
  • Published : 2012.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Biological response modifiers (BRMs) can alter interactions between the immune system and cancer cells to boost, direct, or restore the body's ability to fight disease. Mice with ethylnitrosourea- (ENU) induced leukemia were here used to monitor the therapeutic efficacy of lipopolysaccaride (LPS), Bacillus Calmette Guerin (BCG) and sheep erythrocytes (SRBC). Flow cytometry based CD34+ positivity analysis, clonogenicity, proliferation and ultrastructure studies using scanning electron microscopy (SEM) of stem cells in ENU induced animals with and without BRMs treatment were performed. BRMs improved the stem-stromal relationship structurally and functionally and might have potential for use as an adjunct in human stem cell therapy.

Keywords

References

  1. Ayala F, Dewar R, Kieran M, Kalluri R (2009). Contribution of bone microenvironment to leukemogenesis and leukemia progression. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, 23, 2233-41. https://doi.org/10.1038/leu.2009.175
  2. Baldridge MT, King KY, Boles NC, Weksberg DC, Goodell MA (2010). Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature, 465, 793-7. https://doi.org/10.1038/nature09135
  3. Basak P, Chatterjee S, Das M, et al (2010). Phenotypic alteration of bone marrow HSC and microenvironmental association in experimentally induced leukemia. Current stem cell research & therapy, 5, 379-86. https://doi.org/10.2174/157488810793351677
  4. Beresford JN, Owen ME (1998). Marrow stromal cell culture. Cambridge University Press, Cambridge, Eng. ; New York, Handbooks in practical animal cell biology, pp. xii, 153 p.
  5. Briancon-Marjollet A, Balenci L, Fernandez M, et al (2010). NG2-expressing glial precursor cells are a new potential oligodendroglioma cell initiating population in N-ethyl- N-nitrosourea-induced gliomagenesis. Carcinogenesis, 31, 1718-25. https://doi.org/10.1093/carcin/bgq154
  6. Can A (2007). Niche concept and the hematopoietic stem cell niches. Turkish J hematology, 24, 95-101.
  7. Chatterjee S, Basak P, Das M, et al (2009). Kinetic impairment of haemopoietic stem cells in experimentally induced leukemia and aplastic anemia: an inverse correlation. J stem cells, 4, 179-89.
  8. Chen D, Li Z, Chen T (2011). Increased expression of miR-34a in mouse spleen one day after exposure to N-ethyl-Nnitrosourea. J applied toxicol, 31, 496-8. https://doi.org/10.1002/jat.1640
  9. Corocleanu M (2008). A possible "universal" cancer vaccine that might cause an immune response against emerging cancer cells that originate from any tissue. Med hypotheses, 70, 381-3. https://doi.org/10.1016/j.mehy.2007.04.040
  10. Dennis JE, Charbord P (2002). Origin and differentiation of human and murine stroma. Stem cells, 20, 205-14. https://doi.org/10.1634/stemcells.20-3-205
  11. Dexter TM, Allen TD, Lajtha LG (1977) Conditions Controlling Proliferation of Hematopoietic Stem-Cells Invitro. J cellular physiology, 91, 335-44. https://doi.org/10.1002/jcp.1040910303
  12. Duhrsen U, Hossfeld DK (1996). Stromal abnormalities in neoplastic bone marrow diseases. Annals of hematology, 73, 53-70. https://doi.org/10.1007/s002770050203
  13. Justice MJ, Noveroske JK, Weber JS, et al (1999). Mouse ENU mutagenesis. Human molecular genetics, 8, 1955-63. https://doi.org/10.1093/hmg/8.10.1955
  14. Law S, Maiti D, Palit A, et al (2001) Facilitation of functional compartmentalization of bone marrow cells in leukemic mice by biological response modifiers: an immunotherapeutic approach. Immunology letters, 76, 145-52. https://doi.org/10.1016/S0165-2478(00)00317-5
  15. Li Z, Li L (2006). Understanding hematopoietic stem-cell microenvironments. Trends in biochemical sciences, 31, 589-95. https://doi.org/10.1016/j.tibs.2006.08.001
  16. Meydan N, Grunberger T, Dadi H, et al (1996) Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature, 379, 645-8. https://doi.org/10.1038/379645a0
  17. Mukherjee J, Ghosh A, Sarkar S, et al (2005). T11TS/S-LFA3 induces apoptosis of the brain tumor cells: a new approach to characterise the apoptosis associated genetic changes by arbitrarily primed-PCR. Cancer letters, 222, 23-38. https://doi.org/10.1016/j.canlet.2004.09.014
  18. Nagai Y, Garrett KP, Ohta S, et al (2006). Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity, 24, 801-12. https://doi.org/10.1016/j.immuni.2006.04.008
  19. Nagasawa T, Hirota S, Tachibana K, et al (1996). Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature, 382, 635-8. https://doi.org/10.1038/382635a0
  20. Najman A, Kobari L, Khoury E, et al (1991). Suppression of normal hematopoiesis during acute leukemias. NY Academy of Sciences, 628, 140-7. https://doi.org/10.1111/j.1749-6632.1991.tb17231.x
  21. Potten CS, Loeffler M (1990). Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development, 110, 1001-20.
  22. Rizo A, Vellenga E, De Haan G, Schuringa JJ (2006). Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche? Human molecular genetics 15 Spec No 2, R210-9. https://doi.org/10.1093/hmg/ddl175
  23. Stoica G (2002). ENU-induced ovarian cancer. Methods in molecular biology, 188, 305-14.
  24. Takizawa H, Regoes RR, Boddupalli CS, et al (2011). Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation. J experimental med, 208, 273-84. https://doi.org/10.1084/jem.20101643
  25. Vaquero J, Zurita M, Oya S (1998). Immune-cell system provides the development of extraneural tumors in the ethyl-nitrosourea model of neurocarcinogenesis. Cancer letters, 123, 95-8. https://doi.org/10.1016/S0304-3835(97)00420-5
  26. Verfaillie CM (1993). Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation. Blood, 82, 2045-53.